You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling

Article metrics

Article menu
Immune cell therapies and immune cell engineering
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling

 

Online download statistics by month:

Online download statistics by month: July 2022 to September 2025

AbstractFullPdf
Jul 2022390400127
Aug 202218791905191
Sep 202235336096
Oct 202228028696
Nov 202216116251
Dec 202216817053
Jan 202314715534
Feb 202315415637
Mar 202314914933
Apr 202311812147
May 202310510731
Jun 202313113244
Jul 202310010133
Aug 202313713739
Sep 202312212552
Oct 202310610833
Nov 202313713840
Dec 202311411542
Jan 2024848535
Feb 2024858533
Mar 202413913980
Apr 202411912140
May 202411912056
Jun 202410010045
Jul 202412212774
Aug 2024858435
Sep 2024858541
Oct 202410911246
Nov 202413313554
Dec 202412913349
Jan 202512512649
Feb 202515716041
Mar 202512312355
Apr 202515115542
May 202511712045
Jun 2025979734
Jul 2025110
Sep 2025110
Total683269361933